AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,962.00p
   
  • Change Today:
    610.00p
  • 52 Week High: 12,086.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 1,030,476
  • Market Cap: £185,438m
  • RiskGrade: 123

Regulatory News

1st Quarter Results 25-Apr-2024 07:00 RNS
Result of AGM 11-Apr-2024 17:30 RNS
AstraZeneca increases 2024 dividend by 7% 11-Apr-2024 07:00 RNS
Enhertu approved in US for HER2+ solid tumours 08-Apr-2024 07:00 RNS
Imfinzi improved OS & PFS in limited-stage SCLC 05-Apr-2024 07:00 RNS
Total Voting Rights 02-Apr-2024 15:00 RNS
Voydeya approved in US 02-Apr-2024 07:05 RNS
FDA accepts Dato-DXd BLA for breast cancer 02-Apr-2024 07:00 RNS
Ultomiris approved in the US for NMOSD 25-Mar-2024 07:00 RNS
AstraZeneca to acquire Fusion 19-Mar-2024 07:00 RNS
AstraZeneca to acquire Amolyt 14-Mar-2024 07:00 RNS
Director/PDMR Shareholding 12-Mar-2024 11:00 RNS
Notice of AGM 07-Mar-2024 11:00 RNS
Director/PDMR Shareholding 06-Mar-2024 15:05 RNS
Director/PDMR Shareholding 06-Mar-2024 15:00 RNS
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,962.00p
Change Today 610.00p
% Change 5.37 %
52 Week High 12,086.00
52 Week Low 9,501.00
Volume 1,030,476
Shares Issued 1,550.22m
Market Cap £185,438m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average91.03% below the market average
92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average
Price Trend
36.35% above the market average36.35% above the market average36.35% above the market average36.35% above the market average36.35% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
86.97% below the market average86.97% below the market average86.97% below the market average86.97% below the market average86.97% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average81.84% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 8
Buy 13
Neutral 6
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 25-Apr-2024

Time Volume / Share Price
12:02 38 @ 11,962.00p
12:02 21 @ 11,962.00p
12:01 2 @ 11,962.00p
12:01 13 @ 11,964.00p
12:01 31 @ 11,964.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page